Catalyst Wire Dossier Catalyst Wire Dossier

Encequidar

encequidar
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Encequidar, covering 2025-07-11 to 2025-07-11. Get the full timeline:

Most recent: Clinical Trial Update: Oral Paclitaxel + Encequidar vs IV Paclitaxel in Treatment of HER2 Negative Metastatic Breast Cancer [Phase 3]

See pricing